PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.88%
Revenue growth under 50% of MCHP's 10.00%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
27.53%
Gross profit growth above 1.5x MCHP's 12.34%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-95.92%
Negative EBIT growth while MCHP is at 21.18%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-95.92%
Negative operating income growth while MCHP is at 21.18%. Joel Greenblatt would press for urgent turnaround measures.
22.34%
Net income growth above 1.5x MCHP's 7.14%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
36.36%
EPS growth above 1.5x MCHP's 15.92%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
36.36%
Diluted EPS growth above 1.5x MCHP's 15.92%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.19%
Slight or no buybacks while MCHP is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.28%
Slight or no buyback while MCHP is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-0.19%
Dividend reduction while MCHP stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-45.94%
Negative OCF growth while MCHP is at 62.64%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-90.99%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
103.46%
10Y revenue/share CAGR above 1.5x MCHP's 45.99%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
63.64%
5Y revenue/share CAGR 1.25-1.5x MCHP's 45.99%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
9.95%
3Y revenue/share CAGR under 50% of MCHP's 45.99%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
169.26%
5Y OCF/share CAGR 1.25-1.5x MCHP's 144.97%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
1795.38%
3Y OCF/share CAGR above 1.5x MCHP's 144.97%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
1540.34%
Net income/share CAGR above 1.5x MCHP's 126.88% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
1453.85%
5Y net income/share CAGR above 1.5x MCHP's 126.88%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
274.20%
3Y net income/share CAGR above 1.5x MCHP's 126.88%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
16.10%
Below 50% of MCHP's 79.22%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
11.87%
Below 50% of MCHP's 79.22%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
-15.83%
Negative 5Y dividend/share CAGR while MCHP stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-42.43%
Negative near-term dividend growth while MCHP invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
15.40%
AR growth well above MCHP's 7.40%. Michael Burry fears inflated revenue or higher default risk in the near future.
7.03%
Inventory shrinking or stable vs. MCHP's 15.38%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
6.18%
Asset growth well under 50% of MCHP's 14.86%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
7.50%
Under 50% of MCHP's 17.26%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
3.05%
Debt growth far above MCHP's 6.03%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-12.80%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.